Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892-0810, USA.
Bioorg Med Chem Lett. 2013 Jan 1;23(1):26-36. doi: 10.1016/j.bmcl.2012.10.112. Epub 2012 Nov 5.
Interest is increasing in developing fluorescent ligands for characterization of adenosine receptors (ARs), which hold a promise of usefulness in the drug discovery process. The size of a strategically labeled AR ligand can be greatly increased after the attachment of a fluorophore. The choice of dye moiety (e.g. Alexa Fluor 488), attachment point and linker length can alter the selectivity and potency of the parent molecule. Fluorescent derivatives of adenosine agonists and antagonists (e.g. XAC and other heterocyclic antagonist scaffolds) have been synthesized and characterized pharmacologically. Some are useful AR probes for flow cytometry, fluorescence correlation spectroscopy, fluorescence microscopy, fluorescence polarization, fluorescence resonance energy transfer, and scanning confocal microscopy. Thus, the approach of fluorescent labeled GPCR ligands, including those for ARs, is a growing dynamic research field.
人们对开发用于鉴定腺苷受体 (AR) 的荧光配体越来越感兴趣,这有望在药物发现过程中发挥作用。在将荧光团连接到配体后,可以大大增加策略性标记的 AR 配体的大小。染料部分(例如 Alexa Fluor 488)、连接点和连接子长度的选择可以改变母体分子的选择性和效力。已合成并药理学表征了腺苷激动剂和拮抗剂(例如 XAC 和其他杂环拮抗剂支架)的荧光衍生物。其中一些是用于流式细胞术、荧光相关光谱法、荧光显微镜、荧光偏振、荧光共振能量转移和扫描共聚焦显微镜的有用的 AR 探针。因此,包括 AR 在内的荧光标记 GPCR 配体的方法是一个不断发展的动态研究领域。